Synagis (palivizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** PALIVIZUMAB

**Strength:** 100 mg/mL

**Dosage form:** Injection, Solution

**Route:** Intramuscular

**Labeler:** Swedish Orphan Biovitrum AB (publ)

**Marketing category:** BLA (BLA103770)

**Pharmacologic class:** Antibodies, Monoclonal [CS], Fusion Protein Inhibitors [MoA], Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]